Indonesia

| High TB burden | High HIV burden | High MDR-TB burden |

Population 2011 Estimates of TB burden * 2011 Mortality (excludes HIV+TB) Prevalence (includes HIV+TB) Incidence (includes HIV+TB) Incidence (HIV+TB) Case detection, all forms (%) TB case notifications 2011 New cases Smear-positive Smear-negative Smear-unknown / not done Extrapulmonary Other Total new Other (history unknown) Total new and relapse Number (thousands) 65 (29120) 680 (3101 200) 450 (370540) 15 (1120) 70 (5985) Rate (per 100 000 population) 27 (1248) 281 (130489) 187 (155222) 6.2 (4.48.3)

Tuberculosis profile
(Rate per 100 000 population per year) 242 million *** 120 80 40 0 1990
___

1994

1998

2002

2006

Mortality (excludes HIV+TB)

(%) Retreatment cases 197 797 (63) Relapse 101 750 (32) Treatment after failure Treatment after default 14 054 (4) Other 313 601 Total retreatment

5 348 432 933 994 7 707

(%) (69) (6) (12) (13)

(Rate per 100 000 population) 1000 800 600 400 200 0 1990
___

1994

1998

2002

2006

Prevalence

318 949

Total cases notified Smear-negative/ unknown/ not done 1.3 23 469

321 308 (Rate per 100 000 population per year) 300 Extrapulmonary 0.9 2 776 2011 2.3 0.9 0.1 Yes, in country Yes 200 100 0 1990

New cases M:F ratio Age < 15

Smear-positive 1.5 1 714

Laboratories Smear (per 100 000 population) Culture (per 5 million population) Drug susceptibility testing (per 5 million population) Is second-line drug susceptibility testing available? Is there a national reference laboratory? Treatment success rate 2010 (%) New smear-positive and/or culture-positive New smear-negative/extrapulmonary Retreatment

1994

1998

2002

2006

__
___

Notifications ___ Incidence Incidence (HIV+TB)

Treatment success rate (%) 90

90 86 73

Is rifampicin used throughout treatment for new patients? Number 3 511 1 280 1 182 544

70 Yes 50 (%) (1) (36) (92) (43) 30 1995 1997 1999 2001 2003 2005 2007 2009

TB/HIV 2011 TB patients with known HIV status HIV-positive TB patients HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) HIV-positive TB patients on antiretroviral therapy (ART) HIV-positive people screened for TB HIV-positive people provided with IPT Estimates of MDR-TB burden 2011* % of TB cases with MDR-TB MDR-TB cases among notified pulmonary TB cases Reported cases of MDR-TB 2011 Cases tested for MDR-TB Laboratory-confirmed MDR-TB cases Patients started on MDR-TB treatment Financing TB control Total budget (US$ millions) Available funding (US$ millions) % of budget funded % available funding from domestic sources % available funding from the Global Fund New 1.9 (1.42.5) 5 700 (4 2007 500) New 5 (<1%) 3

__ New smear-positive and/or culture-positive __New smear-negative/extrapulmonary __

Retreatment (Number of patients) 1500 1000 500

Retreatment 12 (8.117) 920 (6201 300) Retreatment 695 (9%) 380 Total 700 383 260 2013 117 31 27 8 92

0 2003 2004 2005 2006 2007 2008 2009 2010

__ HIV-positive TB patients __on CPT __on ART

(US$ millions) 120 100 80 60 40 20 2006 2007 2008 2009 2010 2011 2012

2012 104 49 47 21 65

__

Total budget

__Available funding

* Ranges represent uncertainty intervals

Generated: 2013-02-06

Data: www.who.int/tb/data